Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
4326
DELISTED
GenMark Diagnostics, Inc
GNMK
| $404K | ﹤0.01% |
66,729
+11,330
| +20% | +$70.7K |
|
4327
CALL
Axsome Therapeutics
AXSM
$10.9B
| $403K | ﹤0.01% |
19,900
-39,400
| -66% | -$1.01M |
|
|
ACH
4328
Accendra Health
ACH
$231M
| $403K | ﹤0.01% |
69,327
-9,896
| -12% | -$44.4K |
|
4329
CALL
AES
AES
$10.5B
| $402K | ﹤0.01% |
24,600
+400
| +2% | +$6.44K |
|
|
SNV
4330
CALL
DELISTED
Synovus
SNV
| $401K | ﹤0.01% |
11,200
+4,300
| +62% | +$154K |
|
|
CUTR
4331
DELISTED
Cutera, Inc.
CUTR
| $401K | ﹤0.01% |
13,734
-2,531
| -16% | -$69.6K |
|
|
NGM
4332
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $401K | ﹤0.01% |
28,916
-377
| -1% | -$5.66K |
|
4333
ProShares UltraShort Dow 30
DXD
$37.5M
| $400K | ﹤0.01% |
3,135
+1,960
| +167% | +$258K |
|
4334
Upland Software
UPLD
$12.9M
| $400K | ﹤0.01% |
1,150
-1,840
| -62% | -$764K |
|
|
AYR
4335
CALL
DELISTED
Aircastle Ltd
AYR
| $399K | ﹤0.01% |
17,800
+17,100
| +2,443% | +$367K |
|
|
REV
4336
DELISTED
Revlon, Inc.
REV
| $399K | ﹤0.01% |
17,009
+3,312
| +24% | +$62.5K |
|
|
COOP
4337
DELISTED
Mr. Cooper
COOP
| $398K | ﹤0.01% |
37,522
-224,364
| -86% | -$2.02M |
|
4338
PUT
iShares Select Dividend ETF
DVY
$23.5B
| $398K | ﹤0.01% |
3,900
-2,600
| -40% | -$259K |
|
|
CHK
4339
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $398K | ﹤0.01% |
1,413
-1,294
| -48% | -$421K |
|
4340
WillScot Mobile Mini Holdings
WSC
$4.75B
| $397K | ﹤0.01% |
25,462
-21,437
| -46% | -$321K |
|
4341
National CineMedia
NCMI
$386M
| $396K | ﹤0.01% |
4,826
-1,992
| -29% | -$149K |
|
4342
CALL
Herc Holdings
HRI
$5.67B
| $395K | ﹤0.01% |
8,500
+4,700
| +124% | +$204K |
|
4343
PUT
Robert Half
RHI
$4.1B
| $395K | ﹤0.01% |
7,100
+7,000
| +7,000% | +$395K |
|
4344
Vera Bradley
VRA
$99.5M
| $395K | ﹤0.01% |
39,036
-10,195
| -21% | -$108K |
|
|
AXIA
4345
AXIA Energia
AXIA
$24B
| $394K | ﹤0.01% |
51,862
-1,926
| -4% | -$15.7K |
|
4346
CALL
Golar LNG
GLNG
$5.05B
| $394K | ﹤0.01% |
30,300
+2,700
| +10% | +$39.7K |
|
|
FSB
4347
DELISTED
Franklin Financial Network, Inc.
FSB
| $394K | ﹤0.01% |
13,051
-1,837
| -12% | -$53.2K |
|
4348
e.l.f. Beauty
ELF
$5.26B
| $392K | ﹤0.01% |
22,429
+5,144
| +30% | +$85.8K |
|
4349
Insteel Industries
IIIN
$637M
| $392K | ﹤0.01% |
19,110
-5,004
| -21% | -$99.5K |
|
4350
PUT
KeyCorp
KEY
$24.8B
| $392K | ﹤0.01% |
22,000
+12,800
| +139% | +$221K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.